机械化学消融大隐静脉后同期与分期处理静脉曲张的随机对照试验3年随访
该研究为2016至2017年在赫尔辛基大学医院开展的随机对照试验3年随访,比较机械化学消融大隐静脉主干后同期剥脱与分期泡沫硬化剂处理属支的疗效。结果显示两组再干预率、返流、生活质量等无统计学显著差异,但非劣效分析提示分期策略劣于同期策略,且分期组3年时静脉曲张更多。
要点
- 两组再干预率无统计学显著差异:分期组11.4%(5/44)vs 同期组4.9%(2/41),OR 2.5(95%CI 0.46-13.67,P=.435)。
- 大隐静脉返流、生活质量、大隐静脉状态及症状在两组间无统计学显著差异(P值分别为.603、.238、.255、.112)。
- 非劣效分析提示分期策略劣于同期策略,分期组3年时静脉曲张更多,但未导致症状程度或总体满意度差异。
核心结论
- 对C2-4静脉疾病患者,分期处理属支与同期处理相比提供可接受的中期结局,但优先考虑长期持久疗效时需考虑其潜在劣效性。
研究设计与样本
- 随机对照试验的3年随访,2016至2017年在赫尔辛基大学医院入组85例单侧CEAP C2-4静脉疾病患者,1:1随机分为分期属支泡沫硬化剂治疗组(Group 1)和同期剥脱术组(Group 2),均辅以机械化学消融大隐静脉主干。
主要发现
- 随访期间再干预率:Group 1为11.4%(5/44)(95%CI 0.02-0.21),Group 2为4.9%(2/41)(95%CI -0.02至0.11),OR 2.5(95%CI 0.46-13.67,P=.435)。
- 膝上大隐静脉返流(P=.603)、疾病特异性与健康相关生活质量(P=.238和P=.255)、大隐静脉状态(P=.112)及症状在两组间无统计学显著差异。
- 非劣效分析提示分期策略劣于同期策略;Group 1在3年时静脉曲张数量多于Group 2,但未导致症状程度或总体患者满意度差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mechanochemical ablation is a feasible endovenous nonthermal, nontumescent treatment method for saphenous vein insufficiency. Nevertheless, the ideal approach to managing varicose veins following intervention of the saphenous trunk remains ambiguous. Treatment of varicose veins can be administered either simultaneously or in a staged manner. The aim of this 3-year follow-up study was to present the midterm outcomes of a randomized controlled trial, comparing concomitant and staged treatment of tributaries. METHODS: Venous outpatient clinic patients with unilateral Clinical, Etiological, Anatomical, Pathophysiological (CEAP) C2-4 venous disease were enrolled in a randomized controlled trial during 2016 to 2017 at Helsinki University Hospital. After eligibility assessment of 1149 patients, 85 met the inclusion criteria: age of 20 to 70 years, ultrasound-verified refluxing above-knee great saphenous vein with a diameter of 5 to 10 mm, written consent from patients, and not having deep venous reflux, peripheral artery disease, pregnancy, lymphoedema, body mass index >40 kg/m2, allergy to the sclerosant, a history of deep vein thrombosis, or any form of coagulopathy. Participants were randomized, in a 1:1 ratio, to receive either staged tributary treatment with foam sclerotherapy at 3 months, if required (Group 1), or concomitant phlebectomies (Group 2), adjunct to mechanochemical ablation of the great saphenous trunk. All patients were invited to attend a 3-year follow-up, during which the initially treated leg was assessed with duplex ultrasound. The primary outcome was reintervention rate during follow-up. Secondary outcomes comprised presence of above-knee great saphenous vein reflux, patient satisfaction, status of the great saphenous vein, number of varicose veins, and symptoms at follow-up. RESULTS: During follow-up, 11.4% (n = 5/44) (95% confidence interval [CI], 0.02-0.21) in Group 1 and 4.9% (n = 2/41) (95% CI, -0.02 to 0.11) in Group 2 was in need of additional treatment (Group 1 vs Group 2, odds ratio [OR], 2.5; 95% CI, 0.46-13.67; P = .435). The treatment groups did not elicit statistically significant variances in above-knee great saphenous vein reflux (P = .603), disease-specific and health-related quality of life (P = .238 and P = .255, respectively), status of the great saphenous vein (P = .112), or symptoms. However, noninferiority analysis suggests the staged approach to be inferior to the concomitant approach. Furthermore, Group 1 exhibited more varicosities at 3 years compared with Group 2, but this did not cause differences in the extent of symptoms or overall patient satisfaction. CONCLUSIONS: Staged treatment of tributaries in C2-4 venous disease provides acceptable midterm outcomes compared with simultaneous treatment. However, its potential inferiority should be taken into consideration when prioritizing durable treatment outcomes in the long term.
引用
- Rahman T, Noronen K, Vähäaho S, et al. Three-year follow-up of a randomized controlled trial comparing concomitant and staged treatment of varicose veins following mechanochemical ablation of the great saphenous vein. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 40335021. doi:10.1016/j.jvsv.2025.102255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。